210 related articles for article (PubMed ID: 25001943)
21. Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma.
Lu XC; Yang B; Yu RL; Chi XH; Tuo S; Tuo CW; Zhu HL; Wang Y; Jiang CG; Fu XB; Yang Y; Liu Y; Yao SQ; Dai HR; Cai L; Li BJ; Han WD
Cell Biochem Biophys; 2012 Jan; 62(1):257-65. PubMed ID: 21913005
[TBL] [Abstract][Full Text] [Related]
22. [Influence of albumin and placement time outside the incubator on viability of isolated cytokine-induced killer cells: a simple method for detection].
Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1078-82. PubMed ID: 23895858
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell.
Linn YC; Lau SK; Liu BH; Ng LH; Yong HX; Hui KM
Immunology; 2009 Mar; 126(3):423-35. PubMed ID: 18778291
[TBL] [Abstract][Full Text] [Related]
24. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
Liu J; Wang L; Wang Y; Zhang W; Cao Y
PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
[TBL] [Abstract][Full Text] [Related]
26. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
[TBL] [Abstract][Full Text] [Related]
27. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profiling of CD3+ CD56+ cytokine-induced killer cells.
Wang W; Li R; Meng M; Wei C; Xie Y; Zhang Y; Jiang L; Dong R; Wang C; Zhong Y; Yang F; Tang W; Jin X; Liu B; Hou Z
Sci Rep; 2015 Mar; 5():9571. PubMed ID: 25826780
[TBL] [Abstract][Full Text] [Related]
29. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
30. [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].
Yang XJ; Huang JA; Lei W; Zhu YB; Zhang XG
Ai Zheng; 2006 Nov; 25(11):1329-33. PubMed ID: 17094896
[TBL] [Abstract][Full Text] [Related]
31. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
[TBL] [Abstract][Full Text] [Related]
32. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
[TBL] [Abstract][Full Text] [Related]
34. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
[TBL] [Abstract][Full Text] [Related]
36. Cord blood CD4
Liu A; Wang Q; Yang X; Shen S; Xu Y
Front Biosci (Landmark Ed); 2019 Jun; 24(7):1259-1270. PubMed ID: 31136978
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.
Liu H; Li J; Wang F; Gao Y; Luo Y; Wang P; Li C; Zhu Z
Tumour Biol; 2015 Apr; 36(4):2299-307. PubMed ID: 25417201
[TBL] [Abstract][Full Text] [Related]
38. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
39. Multiple cytotoxic factors involved in IL-21 enhanced antitumor function of CIK cells signaled through STAT-3 and STAT5b pathways.
Rajbhandary S; Zhao MF; Zhao N; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM
Asian Pac J Cancer Prev; 2013; 14(10):5825-31. PubMed ID: 24289584
[TBL] [Abstract][Full Text] [Related]
40. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.
Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Fan ZP; Xu DP; Wang FS
World J Gastroenterol; 2004 Apr; 10(8):1146-51. PubMed ID: 15069715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
